期刊文献+

无瓣膜病变心房纤颤患者缺血性脑卒中相关因素研究 被引量:4

Clinical Analysis of Relationship between Ischemic Stroke and Atrial Fibrillation without Pathology of Valve and Relevant Factors
下载PDF
导出
摘要 目的探讨NVAF患者缺血性脑卒中相关危险因素,评估CHADS2评分预测卒中风险的准确性.方法选择收治并确诊的82例发生缺血性脑卒中的无瓣膜病变心房纤颤患者为病例组,未发生缺血性脑卒中的无瓣膜病变心房纤颤患者82例为对照组.结果与未发生缺血性脑卒中的无瓣膜病变心房纤颤患者相比,缺血性脑卒中无瓣膜病变心房纤颤患者的各项危险因素均明显增高P<0.05;除心衰、高血压、年龄>75岁、糖尿病、脑卒中等传统危险因素外,体重指数超高、冠心病、嗜酒、高脂血症、左房面积扩大及左心室舒张功能降低等因素均致使缺血性脑卒中的风险增高P<0.05.结论 NVAF患者缺血性脑卒中的发病不仅与CHADS2评分上各项危险因素相关,且与体重指数超高、冠心病、嗜酒、高脂血症、左房面积扩大及左心室舒张功能降低等因素亦有密切关系,应针对相关危险因素积极进行治疗,以达到降低缺血性脑卒中发病率的目的. Objective To investigate the risk factors for the ischemic stroke in the atrial fibrillation patients without the pathology of valve,then evaluate the clinical applied value of embolism risk score(CHADS2) on the ischemic stroke.Methods Based on clinical manifestations,laboratory examinations,82 cases that were damaged by the ischemic stroke were selected as case group and the same patients without the ischemic stroke were selected as control group,and the relative parameters were analyzed between the groups.Results All of the values of risk factors were significantly higher in case group than those in control group(P0.05).In addition to traditional risk factors(heartfailure,hypertension,diabetes,up 75 years,stroke),adiposity,coronary disease,alcoholism,hyperlipidemia,left atrial expansion,ventricular diastolic function reducing also increased the risk of ischemic stroke(P0.05).Conclusions Traditional and new risk factors had played important roles in the ischemic stroke and the atrial fibrillation without the pathology of valve.The treatment should be focused on the risk factors,in order to reduce the incidence rate of stroke.
出处 《昆明医科大学学报》 CAS 2013年第3期120-122,145,共4页 Journal of Kunming Medical University
关键词 无瓣膜病变心房纤颤 缺血性脑卒中 危险因素 Atrial fibrillation without the pathology of valve Ischemic stroke Risk factors
  • 相关文献

参考文献10

  • 1GO A S,HYLEK EM,PHILLIPS K A,et al. Prevalence of diagnosedatrial fibrilation in adults [ J ]. JAMA, 2001,285 : 2 370 - 2 375.
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3MOHR. The harvard cooperativc stroke registry Prospecti- ve registr [ J ]. Neurology, 1978,8:754 - 759.
  • 4YAMANOUCHI H. Cerebral embolism in elderly patients with atrial fibrilation [ J ]. Nippon RonenIgakkalsshi, 1993,30 : 348 - 361.
  • 5Hard Early recurrent embolism associated with nonvalvu. lar atrial fibrillation: A retrospective study [ J ]. Stroke, 1983,14:688 - 699.
  • 6PETERSEN, GODTFREDSEN.Embolie complication in p- araxysmal atrial fibrillation [J]. Stroke, 1986, 17:622 - 632.
  • 7戚少华.老年脑卒中危险因素研究[J].老年医学与保健,2002,8(3):140-142. 被引量:6
  • 8Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation:Anal- ysis of pooled data from five randomized trials [ J ]. Arch Intern Med, 1994,154:1 449 - 1 457.
  • 9HART R G, PEARCE L A,MCBRIDE R,et al. Factors a- ssociated with ischaemic stroke during aspirin therapy in a- trial fibrillation.Analsis of 2012 participants in the SPAF I-III clinicaltrials [ J ]. Stroke, 1999,30:1 223 - 1 229.
  • 10王春娟,王春雪,王拥军,王伊龙,赵性泉,刘丽萍,David Z.Wang,李昊,杨中华.中国非瓣膜性心房颤动患者华法林使用不足的相关因素分析[J].中国新药杂志,2012,21(11):1203-1209. 被引量:10

二级参考文献4

共引文献1413

同被引文献88

  • 1Adams H P, Bendixen B H, Kappelle L, et al. Classi-fication of subtype of acute ischemic stroke. Defini-tion for use in a multicenter clinical trail. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41.
  • 2Saposnik G, Gladstone D, Raptis R, et al. Atrial fi-brillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes[J]. Stroke, 2013, 44(1): 99-104.
  • 3Poppe A Y, Majumdar S R, Jeerakathil T, et al. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous throm-bolysis[J]. Diabetes Care, 2009, 32(4): 617-622.
  • 4Shah AJ,Liu X.,Hadidi AS,et al.Early management of atrial fibrillation:from imaging to drugs to ablation[J].Nat Rev Cardiol,2010,7(6):345-354.
  • 5Magnani JW,Rienstra M,Lin H,et al.Atrial fibrillation:current knowledge and future directions in epidemiology and genomics[J].Circulation,2011,124(18):1982-1993.
  • 6Gattellari M,Goumas C,Aitken R,et al.Outcomes for patients with ischaemic stroke and atrial fibrillation:the PRISM study[J].Cerebrovasc Dis,2011,32(4):370-382.
  • 7Camm AJ,Lip GY,De Caterina R,et al,2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association[J].Europace,2012,14(10):1385-1413.
  • 8Turpie AG.Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation[J].Ther Clin Risk Manag,2014,10:197-205.
  • 9Colilla S,Crow A,Simon T,et al.Projected estimates of prevalence and annual growth rate of atrial fibrillation in the United States from a dynamic age-period progression model[J].Circ Cardiovasc Qual 0utcomes,2012,5:A2056.
  • 10Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guide-lines for the management of patients with atrial fibrillation:full text:a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee fox practice guide-lines(writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation)developed in collaboration with the European heart rhythm association and the heart rhythm society[J].Europace,2006,8(9):651-745.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部